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Edited by Felix WielandAbstract The yeast two-hybrid system was used to search for
partners of mouse metastasis-associated protein 1 (Mta1).
Screening of a cDNA library prepared from mouse embryo
yielded positive clones coding for endophilin 3. The site of inter-
action was suggested to be the SH-3-binding domain of Mta1
and SH-3 domain of endophilin 3. This interaction was con-
ﬁrmed by GST pull-down assay in vitro and immunoprecipitation
in vivo. The Mta1 and endophilin 3 transcripts were highly ex-
pressed in testis and brain. But, Mta1 localized mainly in nucleus
and to a lesser extent in cytoplasm while endophilin 3 localized
mainly in cytoplasm. If Mta1 functions in cytoplasm, it might
be involved in the regulation of endocytosis mediated by endophi-
lin 3.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Metastasis-associated protein 1 (Mta1) was originally iso-
lated by diﬀerential screening of a cDNA library using a rat
mammary adenocarcinoma metastatic system. Northern blot
analysis showed that the mRNA expression level of the mta1
gene was higher in highly metastatic cell lines than in a non-
metastatic cell line [1]. It was also discovered that the expres-
sion level of human MTA1 correlates with the metastatic
potential of several human cancer cell lines and tissues [2,3].
Metastasis-associated genes (MTAs) represent a rapidly
growing novel gene family. At present, there are three diﬀerent
members (MTA1, MTA2, and MTA3) and six reported iso-
forms (MTA1, MTA1s, MTA1-ZG29p, MTA2, MTA3, and
MTA3L). MTA1, MTA2 and MTA3 are components of the
nucleosome remodeling and deacetylation complex (NuRD),
which is associated with adenosine triphosphate (ATP)-depen-
dent chromatin remodeling and transcriptional regulation.
MTA proteins, as a part of NuRD, are thought to modulate*Corresponding author. Fax: +81 92 551 4585.
E-mail address: sctakigu@nk-cc.go.jp (S. Takiguchi).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2005.05.069transcription by inﬂuencing the status of chromatin remodel-
ing [4]. MTA1s is the C-terminal truncated form of MTA1,
localizes in the cytoplasm, sequesters the estrogen receptor
(ER) in the cytoplasm, and enhances non-genomic responses
of ER [5].
A recent study has shown that the stimulation of breast can-
cer cells with growth factors induces the expression of MTA1
and its interaction with and repression of the transactivation
function the ER-a, leading to enhanced anchorage-indepen-
dent growth in vitro and hormone independence [6]. Further-
more, MTA1 and MICoA were identiﬁed as partners of
MTA1 using a yeast two-hybrid system [7,8]. They may inter-
act with MTA1 and modulate the transactivation functions of
ER-a.
We have made extensive use of the yeast two-hybrid system
to search for additional binding partners of Mta1. Here we
demonstrate interaction between Mta1 and endophilin 3 in vi-
tro and in vivo, and present a possible cytoplasmic function for
Mta1.2. Materials and methods
2.1. Construction of plasmids
Mouse Mta1 cDNA [9] fragments were obtained by PCR from a
mouse 11-day embryo cDNA library (Clontech, Palo Alto, CA).
The upstream primers were tagged with a BamHI site and the down-
stream primers were tagged with a SalI site. The sequences of the
PCR primers (restriction enzyme sequences are underlined) are
5 0-CGGGATCCGTATGGCCGCCAACATGTAC-30 and 5 0-ACGC-
GTCGACTCAAGGCTGCCGCACGGAG-3 0 for Mta1-F1, 5 0-CG-
GGATCCGTAGCCTGCACATGAGTGC-30 and 5 0-ACGCGTCG-
ACTCAGCGTAGGATCTCACGGC-30 for Mta1-F2, 5 0-CGGGAT-
CCCCATGGCATGCTGCCCG-3 0 and 5 0-ACGCGTCGACCTAG-
TCCTCAATAACAATGG-3 0 for Mta1-F3, and 5 0-CGGGATCC-
TACAAACCCATTGCCCTGC-3 0 and ACGCGTCGACCTAGTC-
CTCAATAACAATGG-30 for Mta1-SH3BD. The PCR-ampliﬁed
fragments were digested with BamHI and SalI and ligated into
BamHI, SalI-digested pAS2-1 (Clontech). Then their sequences were
conﬁrmed.
The EcoRI, BglII-tagged Mta1-F3 fragment was obtained by PCR
from a mouse 11-day embryo cDNA library (Clontech) using a pair
of primes (restriction enzyme sequences are underlined); 5 0-
CGGAATTCCGCCATGGCATGCTGCCCG-30 and 5 0-GAA-
GATCTTCCTAGTCCTCAATAACAATGG-30. The PCR-ampliﬁed
fragment was digested with EcoRI and BglII and ligated into EcoRI,
BglII-digested pAcGHLT-B (PharMingen, San Diego, CA). Thenblished by Elsevier B.V. All rights reserved.
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positive cDNA fragments in a pGAD10 vector were cloned inframe
into a pcDNA3.1/HisA expression vector (Invitrogen, Carlsbad,
CA). For the mammalian expression construct of Mta1-F3, a BamHI,
SalI-tagged Mta1-F3 fragment was cloned into BamHI, XhoI-digested
pcDNA3 (Invitrogen). The myc tag was added to the N-terminus of
Mta1-F3 by PCR.
2.2. Yeast two-hybrid screen and assay
The yeast two-hybrid screen was performed using the Matchmaker
GAL4 Two Hybrid System 2 (Clontech). A mouse 11-day embryo li-
brary in pGAD10 was purchased from Clontech. The pAS2-1-Mta1
bait plasmids and the cDNA library were transfected by the lithium
acetate method into the Y190 yeast strain (Clontech). Selection for
HIS3 reporter gene activation was performed on histidine, tryptophan,
and leucine-deﬁcient agar plates with 25 mM 3-aminotriazole (Sigma
Chemical, St. Louis, MO). Colonies appearing after 7–10 days at
30 C were assayed for b-galactosidase activity utilizing the colony-lift
assay. For quantitative analysis, the colonies were grown in liquid
medium and assayed for b-galactosidase activity using O-nitro-
phenyl-b-D-galactopyranoside (ONPG) as substrate. The plasmid
DNA of positive clones was isolated with phenol and glass beads as
suggested by the maker of the system. Positive two-hybrid protein
interactions were veriﬁed by transfection of the plasmids back into
the Y190 yeast strain together with the original bait or with selected
controls. The plasmids of positive colonies were ampliﬁed in Esche-
richia coli DH5a and sequenced.
2.3. GST pull-down assay
Puriﬁed GST-fusion proteins were generated using a Baculovirus
expression vector system (Pharmingen). The Mta1-F3 transfer vector,
pAcGHLT-B-Mta1-F3, was used for the production of GST-Mta1-F3
fusion protein. Puriﬁed GST fusion protein (2 lg) bound to glutathi-
one–Sepharose 4B beads (Amersham Biosciences, Piscataway, NJ)
was incubated with 20 ll of 35S labeled methionine protein with mod-
erate shaking at 4 C for 2 h in 200 ll of binding buﬀer containing
20 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA (pH 8.0), 0.1%
Nonidet P-40, and 1 mM DTT. The 35S labeled probes were generated
from two-hybrid positive cDNA fragments in a pcDNA3.1/HisA
expression vector using TnT Coupled Reticulocyte Lysate Systems
(Promega, Madison, WI). The bound 35S labeled protein was washed
three times with binding buﬀer and the beads were collected by centri-
fugation. The bound protein was eluted in SDS sample buﬀer, sub-
jected to SDS–PAGE, and detected by autoradiography.
Additionally, 4 lg of GST or GST-Mta1-F3 bound to glutathione–
Sepharose 4B beads was prepared. Highly metastatic mouse melanoma
K-1735 M2 cells (a gift from I.J. Fidler) [10,11] grown in 150-mm
dishes to 70–80% conﬂuency were scraped into lysis buﬀer containing
20 mM Tris (pH 7.4), 250 mM NaCl, 1% Triton X-100, 0.25% sodium
deoxycholate, and protease inhibitor cocktail (Pharmingen). The cell
lysate was incubated on ice for 20 min, vortexed, and centrifuged at
100000 · g for 35 min. The supernatant was precleared with glutathi-
one beads and incubated with the prepared glutathione beads at 4 C
for 2 h. The beads were washed three times with NP40 lysis buﬀer
and boiled in SDS sample buﬀer. The proteins were separated by
SDS–PAGE and subjected to immunoblotting with anti-endophilin 3
or anti-PACSIN 2 antibody (Santa Cruz Biotechnology, Santa Cruz,
CA).2.4. Immunoprecipitation
K-1735 M2 cells grown in 100-mm dishes to 70–80% conﬂuency
were lysed with 1 ml of ice-cold RIPA buﬀer containing 50 mM Tris
(pH 8.0), 150 mMNaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate,
0.1% SDS, and protease inhibitor cocktail (Pharmingen). Cell lysates
containing amounts of equal protein were immunoprecipitated with
anti-Mta1 or pre-immune antibodies (Santa Cruz Biotechnology)
using Protein G–Sepharose 4 Fast Flow (Amersham Biosciences).
The pellet was washed three times with RIPA buﬀer and boiled in
SDS sample buﬀer. The proteins were separated by SDS–PAGE and
subjected to immunoblotting with anti-endophilin 3, anti-Mta1 or
anti-PACSIN 2 antibody (Santa Cruz Biotechnology).
For the reconstitutionof the interactionbetweenMta1 and endophilin
3 in transfected cells, COS7 cells were transfected with pcDNA3-
myc-Mta1-F3 and pcDNA3.1-Xpress-endophilin 3 (175-end). Immuno-precipitation was performed as described above with anti-myc anti-
body (Cell Signaling Technology). The proteins were separated by
SDS–PAGE and subjected to immunoblotting with anti-myc and
anti-Xpress antibodies (Invitrogen).
2.5. Cell fractionation
Cell fractionation was done by the mini-extracts method as de-
scribed with modiﬁcations [12]. Brieﬂy, K-1735 M2 cells grown in
100-mm dishes to 70–80% conﬂuency were collected into 400 ll of buf-
fer containing 10 mM HEPES–KOH (pH 7.8), 10 mM KCl, 0.1 mM
EDTA (pH 8.0), 0.1% Nonidet P-40, 1 mM DTT, and protease inhib-
itor cocktail (Pharmingen). The cell suspensions were vortexed and
centrifuged at 2500 · g for 1 min. The supernatant containing cyto-
plasm was transferred to a fresh tube and the nuclear pellet was resus-
pended in 100 ll of buﬀer containing 50 mM HEPES–KOH (pH 7.8),
420 mM KCl, 0.1 mM EDTA (pH 8.0), 5 mM MgCl2, 20% glycerol,
1 mM DTT, and protease inhibitor cocktail (Pharmingen).
2.6. Immunoperoxidase cell staining
K-1735 M2 cells grown on sterile cover slips overnight at 37 C were
washed with PBS, ﬁxed for 10 min in 1% formalin in PBS, and washed
three times in PBS. Staining was performed with anti-Mta1 or anti-
endophilin 3 antibodies raised against a peptide located near the car-
boxyl terminus of Mta1 or endophilin 3 (Santa Cruz Biotechnology)
using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame,
CA) as suggested by the manufacturer of the kit.3. Results
3.1. Identiﬁcation of endophilin 3 and Spag5 as Mta1-interacting
proteins in the yeast two-hybrid screen
A mouse 11-day embryo library was screened with the
pAS2-1-Mta1 baits to elucidate any Mta1-interacting proteins.
The yeast two-hybrid screen was performed under stringent
conditions. More than 106 transformants were screened with
each bait which derived from four diﬀerent parts of Mta1
(Fig. 1A). When pAS2-1-Mta1-F1 and pAS2-1-Mta1-F2 were
used as baits, several clones grew on the selection plates but
none of them were positive for b-galactosidase activity. When
pAS2-1-Mta1-F3 and pAS2-1-Mta1-SH3BD were used as
baits, one and three b-galactosidase-positive clones which har-
bored pGAD10-Spag5 (residue 867–897 + 915-end) and
pGAD10-endophilin 3 (two clones of residue 175-end and a
clone of residue 189-end) prey plasmids were obtained, respec-
tively. Positive two-hybrid protein interactions were veriﬁed by
transfection of the plasmids back into the host together with
the original bait or with selected controls. As a result, positive
interaction was observed between endophilin 3 (residues 175-
end) and Mta-SH3BD or Mta1-F3, and between Spag5 and
Mta1-F3 (Fig. 1B). Mta1 and endophilin 3 seem to interact
through their SH3-binding domain (residue 697–705) and
SH3 domain (residue 286–346), respectively.
3.2. Mta1 interacts with endophilin 3 in vitro
To independently conﬁrm the results obtained with the two-
hybrid assay, we performed GST pull-down assays. A GST-
Mta1-F3 fusion protein was produced using the Baculovirus
expression vector system and bound to glutathione–Sepharose
beads. 35S labeled methionine endophilin 3 (residue 175-end)
or Spag5 (867–897 + 915-end) were applied to the beads and
after extensive washing, the proteins were eluted from the
beads, size fractionated by SDS–PAGE and visualized by
autoradiography. GST-Mta1-F3 protein speciﬁcally interacted
with endophilin 3, whereas GST alone failed to interact with
endophilin 3. No speciﬁc interaction could be observed
Fig. 1. Yeast two-hybrid interactions between Mta1 and other proteins. (A) Schematic representation of Mta1 protein demonstrating the regions
utilized as bait for yeast two-hybrid screening of a mouse embryo cDNA library. Various protein motifs are indicated. Numbers represent the
positions of amino acids. (B) b-Galactosidase activity assessed by colony-lift assay and liquid culture assay. The Y190 yeast strain was transformed
with the indicated bait and prey plasmids. The blue of the colony-lift assay appears as dark gray. The b-galactosidase activity was calculated as
nanomoles of ONPG hydrolyzed per min. The combination of pVA3-1 (murine p53) and pTD1-1 (SV40 large T antigen) is a positive control. The
combination of pAS2-1 (bait vector) and pTD1-1 is a negative control. Values are the average of four experiments and the standard deviation.
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between GST-Mta1-F3 and endophilin 3 was also conﬁrmed
using lysate from high metastatic mouse melanoma K-1735
M2. A GST-Mta1-F3 fusion protein bound to glutathione–
Sepharose beads was mixed with the lysate, and after extensive
washing, the proteins were eluted from the beads, size fraction-
ated by SDS–PAGE and immunoblotted with anti-endophilin
3 antibodies. GST-Mta1-F3 protein speciﬁcally interacted with
endogenous endophilin 3 (42 kDa), whereas GST alone failed
to interact with endophilin 3. PACSIN 2, another SH3-domain
protein, failed to interact with GST-Mta1-F3 (Fig. 2B). Taken
together, these results conﬁrm the interaction between Mta1
and endophilin 3, ﬁrst identiﬁed in the yeast two-hybrid
screening.
3.3. Mta1 interacts with endophilin 3 in vivo
We next addressed whether Mta1 in native cells can bind to
endophilin 3. Endophilin 3 was immunoprecipitated from the
lysate of mouse melanoma K-1735 M2 cells using a speciﬁc
anti-Mta1 antibody, whereas pre-immune serum failed to
immunoprecipitate endophilin 3. But the intensity of the band
was so weak that only a small fraction of these proteins seemed
to interact with each other. PACSIN 2, another SH3-domain
protein, was not immunoprecipitated using the anti-Mta1 anti-
body (Fig. 2C). Taken together, the data conﬁrm the associa-
tion of Mta1 with endophilin 3 in vivo. To further conﬁrm theinteraction of Mta1 with endophilin 3 in vivo, we expressed
myc-Mta1-F3 in COS7 cells together with Xpress-tagged endo-
philin 3 (residue 175-end) (Fig. 2D). In immunoprecipitates of
cells expressing both myc-Mta1-F3 and Xpress-endophilin 3
(residue 175-end) eﬃcient coprecipitation was observed. Thus,
it appears that Mta1 interacts with endophilin 3 through their
SH3 binding domain and SH3 domain respectively in vivo.
3.4. Subcellular localization of Mta1 and endophilin 3
To assess the subcellular localization of Mta1 and endophi-
lin 3, we ﬁrst performed the fractionation of high metastatic
mouse melanoma K-1735 M2 cells and examined the expres-
sion of Mta1 and endophilin 3 by immunoblotting. Mta1
was detected both in nucleus and to a lesser extent in cyto-
plasm. In contrast, endophilin 3 was detected mainly in cyto-
plasm (Fig. 3A). Next we performed immunoperoxidase
staining with anti-Mta1 and anti-endophilin 3 antibodies
against K-1735 M2 cells. Mta1 was detected mainly in nucleus,
while endophilin 3 could be detected mainly in cytoplasm (Fig.
3B). Taken together, Mta1 and endophilin 3 probably interact
in the cytoplasm of K-1735 M2 cells.
3.5. Tissue distribution of Mta1 and endophilin 3
To determine the expression pattern of Mta1 and endophilin
3, Northern blot analyses were employed using a total RNA
blot derived from adult C57BL/6 mice. An Mta1 cDNA probe
Fig. 2. Direct interaction between Mta1 and endophilin 3 in vitro and in vivo. (A) Binding of endophilin 3 (residue 175-end) and Spag5 (867–
897 + 915-end) with GST-Mta1-F3 in vitro. In vitro translated endophilin 3 and Spag5 radiolabeled with [35S] methionine were incubated with GST
and GST-Mta1-F3 bound to glutathione Sepharose beads. Endophilin 3 did not bind to GST alone but did bind to GST-Mta1-F3. The radiolabeled
luciferase protein was used as a negative control. (B) Binding of endogenous endophilin 3 with GST-Mta1-F3 in vitro. GST and GST-Mta1-F3
bound to glutathione–Sepharose beads were incubated with K-1735 M2 cell lysate. Proteins bound to the beads were separated by SDS–PAGE and
immunoblotted with anti-endophilin 3 or anti-PACSIN 2 antibody. (C) Binding of endophilin 3 with Mta1 in vivo. Lysates of K-1735 M2 cells were
immunoprecipitated with anti-Mta1 or pre-immune antibodies. The pellet was separated by SDS–PAGE and subjected to immunoblotting with anti-
endophilin 3, anti-MTA1 or anti-PACSIN 2 antibody. (D) The myc-Mta1-F3 immunoprecipitate contained Xpress-endophilin 3 (residue 175-end).
COS7 cells were transfected with pcDNA3.1-Xpress-endophilin 3 (175-end) alone or together with pcDNA3-myc-Mta1-F3. Cell lysates were
subjected to anti-myc immunoprecipitation, and coprecipitation of Xpress-endophilin 3 (residue 175-end) was detected by immunoblotting with anti-
Xpress antibody.
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endophilin 3 cDNA probe identiﬁed a RNA transcript of
approximately 1.8 kb (Fig. 4). The sizes of the transcripts were
consistent with the former results [9,13]. Mta1 transcripts
were observed in all tissues examined. Endophilin 3 transcripts
were observed in brain and testis. The expression of Mta1 and
endophilin 3 was very similar in that high levels were observed
in testis and brain.4. Discussion
To elucidate novel functions of Mta1, we have performed
yeast two-hybrid screening to ﬁnd additional binding partners
of Mta1. Through extensive screening of a mouse 11-day em-
bryo cDNA library, endophilin 3 was found to interact with
Mta1. The interaction seems to occur through the SH3 binding
domain of Mta1 and SH3 domain of endophilin 3. The inter-
Fig. 3. Subcellular localization of Mta1 and endophilin 3. (A) Analysis
of subcellular localization of Mta1 and endophilin 3 in highly
metastatic K-1735 M2 mouse melanoma cells. The cells (1 · 105) were
harvested, fractionated into nuclear and cytoplasmic lysates, and
subjected to immunoblotting. (B) Immunoperoxidase staining of K-
1735 M2 cells. The nucleus was mainly stained with anti-Mta1
antibody and cytoplasm was mainly stained with anti-endophilin3
antibody. N, nucleus; C, cytoplasm; HE, hematoxylin and eosin stain;
bar, 20 lm.
Fig. 4. Tissue distribution of Mta1 and endophilin 3. Total RNA from
diﬀerent mouse organs of 6-week old C57BL/6 mice was analyzed by
the Northern blotting. A single 3.0 and 1.8-kb signal was detected with
the Mta1 and endophilin 3 cDNA probe, respectively. Hybridization
to the GAPDH cDNA probe is shown as a control.
Y. Aramaki et al. / FEBS Letters 579 (2005) 3731–3736 3735action was conﬁrmed in vitro with a GST pull-down assay and
in vivo with an immunoprecipitation assay.
Endophilin 3 is part of a family of proteins (endophilin 1–3,
also referred to as SH3p4/8/13, SH3GL1-3, and SH3d2a-c)
that contained a Grb2-like Src homology 3 (SH3) domain
and were identiﬁed as binding partners of Synaptojanin
[14,15]. The endophilin 1–3 transcripts were diﬀerentially ex-
pressed in rat tissues: endophilin 1 mRNA was detected only
in brain, endophilin 2 mRNA was detected at similar levels
in multiple tissues, and endophilin 3 mRNA was present inbrain and testis [15]. Our data showed that mouse endophilin
3 was highly expressed in testis and brain where Mta1 was also
highly expressed in the same blot. However, the subcellular
distribution of Mta1 and endophilin 3 diﬀered. Mta1 was de-
tected mainly in nucleus and to a lesser extent in cytoplasm,
while endophilin 3 was detected mainly in cytoplasm. Previous
reports that Mta1 is expressed exclusively in nucleus [5,9,16]
and endophilin 3 is expressed mainly in cytoplasm [17,18] lar-
gely support our data except for the localization of Mta1 in
cytoplasm. If endophilin 3 and Mta1 interact in cytoplasm in
testis and brain, they should have functions related to endocy-
tosis. Although we could not conﬁrm the interaction between
Mta1 and Spag5 with the GST pull-down assay, Spag5 is an
interesting binding partner as it is also predominantly ex-
pressed in testis in pachytene spermatocytes, and has similarity
to the mitotic spindle protein Deepest [19].
The most extensively studied isoform of endophilin is endo-
philin 1, which functions during the recycling of synaptic ves-
icles [20–24]. Endophilin 1 binds, via its C-terminal SH3
domain, to the SH-3-binding domain of amphyphysin [25],
dynamin [15], and synaptojanin [14,15]. Recent studies
have shown that the endophilin-mediated recruitment and sta-
bilization of synaptojanin on synaptic vesicles is crucial for
clathrin-mediated endocytosis [26,27]. Furthermore, endophi-
lin 1 promotes the ligand-induced downregulation of EGF
receptors and c-Met by binding through its SH3 domain with
a regulatory component of clathrin-coated vesicles and by
transporting the growth-factor-receptor complex to lysosome
[28,29]. If endophilin 3 has similar functions to endophilin 1,
it might competitively interact through its SH-3 domain with
a regulatory component such as amphyphysin, dynamin, and
synaptojanin, and with Mta1. The interaction of Mta1 with
endophilin 3 may prevent the late events of clathrin-coated
vesicle formation. By inhibiting the downregulation of
growth-factor-receptors, Mta1 may induce some of its onco-
genic eﬀects. However, a recent study has shown an inhibitory
role for endophilin 3 in receptor-mediated endocytosis [18]. In
this case, Mta1 could stimulate the process of endocytosis.
Mta1 was also shown to functionally interact with ligand-
bound estrogen receptor (ER) and repress the transactivation
functions of ER [6]. If endophilin 3 is shown to undergo nucle-
ar shuttling, it might take Mta1 competitively from the ER-
NuRD protein complex and activate the genomic action of
ER. In conclusion, this study has shown that Mta1 and endo-
philin 3 interact directly in vitro and in vivo, and suggested
that they modulate antagonistically the process of endocytosis.
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